Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 1/20 | 0.36 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.36 |
| ▸ | CDK1 | P06493 | 1/20 | 0.36 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.36 |
| ▸ | GSK3A | P49840 | 1/20 | 0.36 |
| ▸ | GSK3B | P49841 | 1/20 | 0.36 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | HPGD | P15428 | 2/20 | 0.35 |
| ▸ | TERT | O14746 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | XBP1 | P17861 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6004323 | 0.99 | CCNB2 (0.35) | KCNH2CCNB2CDK1CCNB1GSK3A | |
| SCHEMBL6003423 | 0.99 | TERT (0.34) | KCNH2CCNB2CDK1CCNB1GSK3A | |
| SCHEMBL6003931 | 0.97 | TERT (0.33) | KCNH2CCNB2CDK1CCNB1GSK3A | |
| SCHEMBL15468129 | 0.91 | KCNH2 (0.42) | KCNH2CCNB2CDK1CCNB1GSK3A | |
| SCHEMBL8601755 | 0.91 | KCNH2 (0.42) | KCNH2CCNB2CDK1CCNB1GSK3A | |
| SCHEMBL433614 | 0.91 | KCNH2 (0.42) | KCNH2CCNB2CDK1CCNB1GSK3A | |
| SCHEMBL9438134 | 0.91 | KCNH2 (0.42) | KCNH2CCNB2CDK1CCNB1GSK3A | |
| SCHEMBL1194293 | 0.89 | KCNH2 (0.39) | KCNH2MAPTHSD17B10KDM4EALDH1A1 | |
| SCHEMBL3475623 | 0.85 | MAPT (0.41) | CCNB2CDK1CCNB1GSK3AGSK3B | |
| SCHEMBL14701508 | 0.83 | KDM4E (0.36) | KCNH2CCNB2CDK1CCNB1GSK3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060293249-A1 | Porphyrin derivatives | PHOTOBIOTICS LIMITED | 2006-12-28 | — | — | US | disclosed |
| EP-1562951-A2 | PORPHYRIN DERIVATIVES | Photobiotics Ltd. (GB) | 2005-08-17 | — | — | EP | disclosed |
| WO-2004046151-A2 | PORPHYRIN DERIVATIVES | PHOTOBIOTICS LIMITED (GB) | 2004-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060293249-A1 | Porphyrin derivatives | SLC2A3, SLC2A2, SCO2 | KCNH2 110/4885CCNB2 1125/4885CDK1 2656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.